Technology

Screening for atrial fibrillation with 6 wrist-worn wearable devices proved more cost effective than no screening and had greater relative benefit than using traditional modalities.

Use of wearable activity trackers increased daily time spent walking by 40 minutes and was linked to a 2-lb weight loss across age groups and populations.

A free, automated online behavioral weight loss program led to a mean 5% reduction in weight over 12 weeks without clinician involvement, a new study reports.

The cloud-based machine learning algorithm allows the stethoscope to identify and differentiate between innocent and structural murmurs that may signal valve disease.

Called SMART WARS, a new study assessed diagnostic utility of the 2 wearable devices in older adults and considered combined device/clinician interpretation of ECG readings.

Characteristics associated with discussions of wearable devices during primary care visits include female sex, higher income, and obesity, showed new study.

Apple recently announced a new software release that will allow Apple Watch users access to health care-focused features and apps.

ADA 2022: Use of flash continuous glucose monitoring in T2D patients not on insulin also reduced HbA1c and glycemic variability, a new study finds.

ADA 2022: Large national study found that CGM use had a positive effect on glycemic control and acute complications in T2D in the Veterans Health Administration.

ADA 2022. Tirzepatide was associated with significantly greater TIR, many fewer episodes of hypoglycemia, and less glycemic excursion vs insulin degludec in SURPASS-3 CGM.

ADA 2022: Primary care patients with T2D and HbA1c >7.5% achieved as much as a 1.5% drop in HbA1c after initiating real time continuous glucose monitoring.

ADA 2022: Patients with T2D who received a treatment intervention powered by artificial intelligence achieved a remission rate of more than 80%.

The Abbott FreeStyle Libre 3 is the smallest, thinnest, and most accurate 14-day CGM with a 7.9% MARD, the company says.

The wearable device allows users to monitor their health while also performing their regular daily activities.

New study presented at Heart Rhythm 2022 showed applying AI to an Apple Watch ECG can effectively identify LV dysfunction in a nonclinical setting.

DiabetesWise Pro, created at Stanford University, provides an unbranded, unbiased guide to matching diabetes technology to patient needs, access, and lifestyle.

Initiating diabetes technology of any kind is a big step for patients, but also for a lot of primary care clinicians. If you have concerns, these myths and facts are for you.

To recommend, or not recommend: that is the question clinicians may ponder when considering education-focused apps for patients. Here, 5 points to help decide.

ACC 2022. Study assessed hypertension-related TikTok videos and found that 42% addressed alternative medicine, more than twice the number that focused on medical treatments.

ACC 2022. A new systematic review suggests skin melanin content may impede accurate recording of heart rate and rhythm by wearable devices.

Cardiovascular-health-focused company Eko redesigned its app to enable screening for cardiovascular disease within seconds during a physical exam.

COVID-19 accelerated telehealth as a standard option but what services will it be best suited for now? A new survey suggests the future.

Is virtual reality a viable option for chronic pain management? A new scoping review suggests it has potential. Here, key findings for primary care.

Greatest improvements in A1c, %TIR, and other glycemic parameters were seen in patients treated with ≤1 medication, in another challenge to current payer restrictions.

CGMs have revolutionized diabetes management for patients and healthcare providers alike. This slide show summarizes the most recent enhancements.

Headspace, Calm, and 3 more apps for COVID-19 frontline health care workers who need antidotes to anxiety and stress everywhere they go.

AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.

AHA 2021: Novel software algorithm used in Fitbit wearable devices accurately detected undiagnosed atrial fibrillation about 98% of the time, showed results of the Fitbit Heart Study.

AHA Scientific Sessions 2021: Employment status and higher caregiver burden were linked to increased engagement with a videoconferencing-based intervention to reduce the risk of CVD.